Dr Jean-Pierre Lin

Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, King's Health Partner
Consultant Paediatric Neurologist / President, British Paediatric Neurology Association

Jean-Pierre Lin qualified in medicine in 1983 from Edinburgh University Medical School training initially in medicine, adult neurology and paediatrics. He obtained an Edinburgh University George Guthrie Research Fellowship (1990-4) leading to a PhD in physiology at Edinburgh University on ‘Motor Assessments in Cerebral Palsy’ under E Geoffrey Walsh, motor physiologist and J Keith Brown, paediatric neurologist.

In 1994 he received the American Academy of Cerebral Palsy and Developmental Medicine Richmond Paine Cerebral Palsy Award and was appointed Senior Registrar in Paediatric Neurology at Great Ormond Street Hospital for Children, becoming Consultant Paediatric Neurologist in 1996 at the Evelina London Children’s Hospital, Guy’s & St Thomas’ NHS FoundationTrust. He has developed many services for children with movement disorders, including the One Small Step Gait and Movement Laboratory; the Movement Therapy Clinics aimed particularly at delivering intramuscular botulinum toxin A injections for abnormal movements and postures. He leads the Complex Motor Disorders Assessment and Management Service (CMDS) 2006-present thanks to a New Services and Innovation Grant (G060708) from the Guy’s and St Thomas’ Charity from April 2007-9 to deliver Deep Brain Stimulation (DBS) for children with dystonia.

He is President of the British Paediatric Neurology Association (BPNA), and chairs the BPNA Movement Disorders Clinical-Research-Network an advisor to Dystona Europe, and on the board of the European Paediatric Neurology Society.

dont miss

Advances in Deep Brain Stimulation Neuromodulation for Movement Disorders in Children

Movement disorders profoundly affect the lives of children, are often painful, interrupt sleep, sitting and daily care while reducing activity and participation in education, play and social interaction.

Medication and physical measures are often ineffective and adverse effects common. Deep brain stimulation (DBS) can profoundly reduce the impact of an increasingly recognized number of genetic movement disorders including dystonia (twisting and writhing postures and movements), chorea (dance-like rapid movements), myoclonus (lightning jerks) and tremors. A key area of clinical research is the effect of DBS neuromodulation on dystonia and chorea (also known as dyskinesia) in children with cerebral palsy (CP).

The benefits of DBS seem related to the proportion-of-life-lived with CP, indicating that early or very early DBS intervention may be most effective at a time when the developing brain’s ‘critical’ and ‘sensitive windows’ are still open to influence and particularly before the onset of permanent musculoskeletal deformity.


  • Dr Hugo Spiers: Speaking at the European Neurological Convention

    Dr Hugo Spiers
    University College London

    Developing a mobile app help diagnose spatial navigation problems in early stage Alzheimer’s dementia

  • Simon B Dickinson: Speaking at the European Neurological Convention

    Simon B Dickinson
    TalarMade Ltd

    Maximising function for patients with a drop foot

  • Dr Jeremy Isaacs: Speaking at the European Neurological Convention

    Dr Jeremy Isaacs
    St George's University Hospitals NHS FT

    Diagnosis of young onset dementia

  • Professor Michael Hornberger: Speaking at the European Neurological Convention

    Professor Michael Hornberger
    Norwich Medical School, University of East Anglia

    Getting lost in dementia

  • Armin Schnürer: Speaking at the European Neurological Convention

    Armin Schnürer
    g.tec medical engineering

    Brain-Computer Interfaces (BCI) for stroke rehabilitation and consciousness assessment